Serotonin 3 Receptor Signaling Regulates 5-fluorouracil-mediated Apoptosis Indirectly Via TNF-α Production by Enhancing Serotonin Release from Enterochromaffin Cells
Overview
Authors
Affiliations
Antagonists of the 5-hydroxytryptamine (serotonin) 3 receptor (5-HTR) have anti-inflammatory and anti-apoptotic activities, but the detailed, underlying mechanisms are not well understood. We focused on anti-apoptotic activities via 5-HTR signaling to clarify the underlying mechanisms. Mice were administered 5-fluorouracil (5-FU), which induced apoptosis in intestinal epithelial cells. Coadministration with 5-HTR antagonists or agonists tended to decrease or increase the number of apoptotic cells, respectively. In serotonin 3A receptor (5-HTR) null (HTR3A) mice, the number of apoptotic cells induced by 5-FU was decreased compared with that in wild-type (WT) mice. Bone marrow (BM) transplantation was performed to determine if BM-derived immune cells regulated 5-FU-induced apoptosis, but they were found to be unrelated to this process. Data from 5-HTR/enhanced green fluorescent protein reporter mice revealed that 50% of enterochromaffin (EC) cells expressed 5-HTR, but the number of apoptotic cells induced by 5-FU in the intestinal crypt organoids of HTR3A mice was not altered compared with WT mice. In contrast, plasma 5-HT concentrations in WT mice but not in HTR3A mice administered 5-FU were increased significantly. In conclusion, 5-HTR signaling may enhance 5-HT release, possibly from EC cells intravascularly, or paracrine, resulting in increases in plasma 5-HT concentration, which in turn, enhances apoptotic activities induced by 5-FU.-Mikawa, S., Kondo, M., Kaji, N., Mihara, T., Yoshitake, R., Nakagawa, T., Takamoto, M., Nishimura, R., Shimada, S., Ozaki, H., Hori, M. Serotonin 3 receptor signaling regulates 5-fluorouracil-mediated apoptosis indirectly via TNF-α production by enhancing serotonin release from enterochromaffin cells.
Vera G, Lopez-Gomez L, Giron R, Martin-Fontelles M, Nurgali K, Abalo R Int J Mol Sci. 2023; 24(19).
PMID: 37833878 PMC: 10572311. DOI: 10.3390/ijms241914430.
Li G, Liu L, Yin Y, Wang M, Wang L, Dou J Front Pharmacol. 2022; 13:999115.
PMID: 36204230 PMC: 9530632. DOI: 10.3389/fphar.2022.999115.
Valeri A, Chiricosta L, Gugliandolo A, Pollastro F, Mazzon E Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215230 PMC: 8875351. DOI: 10.3390/ph15020117.
Shen Q, Xiao X, Aierken A, Yue W, Wu X, Liao M J Cell Mol Med. 2020; 24(16):9472-9477.
PMID: 32594644 PMC: 7361928. DOI: 10.1111/jcmm.15541.
He Y, Sun X, Rong W, Yang R, Liang H, Qi Y Sci Rep. 2020; 10(1):10180.
PMID: 32576895 PMC: 7311394. DOI: 10.1038/s41598-020-67152-w.